Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder.

Détails

Ressource 1Télécharger: s13011-018-0145-6.pdf (536.80 [Ko])
Etat: Serval
Version: Final published version
ID Serval
serval:BIB_F1A6E941F42A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Effects of substance use disorder on treatment process and outcome in a ten-session psychiatric treatment for borderline personality disorder.
Périodique
Substance abuse treatment, prevention, and policy
Auteur(s)
Penzenstadler L., Kolly S., Rothen S., Khazaal Y., Kramer U.
ISSN
1747-597X (Electronic)
ISSN-L
1747-597X
Statut éditorial
Publié
Date de publication
26/02/2018
Peer-reviewed
Oui
Volume
13
Numéro
1
Pages
10
Langue
anglais
Notes
Publication types: Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Dual diagnosis is common in Borderline Personality Disorder (BPD), one of the most common being Substance Use Disorder (SUD). Previous studies have shown that general psychiatric management (GPM) was effective in reducing borderline symptoms. In the present study, we tested whether the short GPM was as effective in the BPD + SUD as in the BPD group.
We analysed a group of 99 patients presenting a BPD. 51 of these patients presented a SUD. The BPD group and the BPD + SUD group received a manual-based short variant of the GPM treatment. Previous studies have shown that a 10-session version of GPM was effective in reducing borderline symptoms at the end of the treatment (Psychother Psychosom 83:176-86, 2014).
We found no significant difference in the reduction of general symptoms, which diminished in both groups. The specific borderline symptoms were also reduced in both groups, but there was a slightly higher reduction of the borderline symptoms in the SUD group. The therapeutic alliance progressed positively in all groups. Moreover, the alliance increased more over time in the SUD group.
The short variant of GPM seems to be effective in BPD treatment independently from the presence of SUD. Therefore, this treatment could be an effective entry-level treatment for patients with dual diagnosis as well as patients with BPD only. Further studies are needed to confirm efficacy and long-term outcome.
The trial was registered at ClinicalTrial.gov (identifier NCT01896024 ).
Mots-clé
Adult, Behavior Therapy, Borderline Personality Disorder/epidemiology, Borderline Personality Disorder/therapy, Comorbidity, Diagnosis, Dual (Psychiatry), Female, Humans, Male, Middle Aged, Psychotherapy, Brief, Substance-Related Disorders/epidemiology, Substance-Related Disorders/therapy, Treatment Outcome, Young Adult
Pubmed
Web of science
Open Access
Oui
Création de la notice
27/02/2018 12:30
Dernière modification de la notice
09/05/2019 3:19
Données d'usage